Mikhailidis DP - Search Results

1

Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.

Liberopoulos EN, Tsouli S, Mikhailidis DP, Elisaf MS. Liberopoulos EN, et al. Among authors: mikhailidis dp. Curr Drug Targets. 2006 Feb;7(2):211-28. doi: 10.2174/138945006775515419. Curr Drug Targets. 2006. PMID: 16475962 Review.

2

Effect of non-statin lipid lowering and anti-obesity drugs on LDL subfractions in patients with mixed dyslipidaemia.

Florentin M, Tselepis AD, Elisaf MS, Rizos CV, Mikhailidis DP, Liberopoulos EN. Florentin M, et al. Among authors: mikhailidis dp. Curr Vasc Pharmacol. 2010 Nov;8(6):820-30. doi: 10.2174/157016110793563825. Curr Vasc Pharmacol. 2010. PMID: 20180768 Review.

3

Pleiotropic effects of nicotinic acid: beyond high density lipoprotein cholesterol elevation.

Florentin M, Liberopoulos EN, Kei A, Mikhailidis DP, Elisaf MS. Florentin M, et al. Among authors: mikhailidis dp. Curr Vasc Pharmacol. 2011 Jul 1;9(4):385-400. doi: 10.2174/157016111796197279. Curr Vasc Pharmacol. 2011. PMID: 21314635 Review.

4

Diagnosis and management of the metabolic syndrome in obesity.

Liberopoulos EN, Mikhailidis DP, Elisaf MS. Liberopoulos EN, et al. Among authors: mikhailidis dp. Obes Rev. 2005 Nov;6(4):283-96. doi: 10.1111/j.1467-789X.2005.00221.x. Obes Rev. 2005. PMID: 16246214 Review.

5

Management of high triglycerides: what non-specialists in lipids need to know.

Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP. Liberopoulos EN, et al. Among authors: mikhailidis dp. Hellenic J Cardiol. 2005 Jul-Aug;46(4):268-72. Hellenic J Cardiol. 2005. PMID: 16159006 Free article. No abstract available.

6

Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?

Liberopoulos EN, Elisaf MS, Tselepis AD, Archimandritis A, Kiskinis D, Cokkinos D, Mikhailidis DP. Liberopoulos EN, et al. Among authors: mikhailidis dp. Platelets. 2006 Feb;17(1):1-6. doi: 10.1080/09537100500237004. Platelets. 2006. PMID: 16308180 Review.

7

Dyslipidaemia, hypercoagulability and the metabolic syndrome.

Kakafika AI, Liberopoulos EN, Karagiannis A, Athyros VG, Mikhailidis DP. Kakafika AI, et al. Among authors: mikhailidis dp. Curr Vasc Pharmacol. 2006 Jul;4(3):175-83. doi: 10.2174/157016106777698432. Curr Vasc Pharmacol. 2006. PMID: 16842135 Review.

8

Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

Athyros VG, Mikhailidis DP, Kakafika AI, Karagiannis A, Hatzitolios A, Tziomalos K, Ganotakis ES, Liberopoulos EN, Elisaf M. Athyros VG, et al. Among authors: mikhailidis dp. Curr Drug Targets. 2007 Mar;8(3):483-8. doi: 10.2174/138945007780058933. Curr Drug Targets. 2007. PMID: 17348840 Review.

9

Analysis of antihypertensive effects of statins.

Milionis HJ, Liberopoulos EN, Elisaf MS, Mikhailidis DP. Milionis HJ, et al. Among authors: mikhailidis dp. Curr Hypertens Rep. 2007 Jun;9(3):175-83. doi: 10.1007/s11906-007-0032-4. Curr Hypertens Rep. 2007. PMID: 17519121 Review.

10

Vitamin D and metabolic syndrome: is there a link?

Florentin M, Elisaf MS, Mikhailidis DP, Liberopoulos EN. Florentin M, et al. Among authors: mikhailidis dp. Curr Pharm Des. 2010 Oct;16(30):3417-34. doi: 10.2174/138161210793563509. Curr Pharm Des. 2010. PMID: 20819071 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,406 results

Search Page